Open Access

Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations

  • Sebastian Ochsenreither1Email author,
  • Alberto Fusi1,
  • Antonia Busse1,
  • Dirk Nagorsen1,
  • David Schrama2,
  • Jürgen Becker2,
  • Eckhard Thiel1 and
  • Ulrich Keilholz1
Journal of Translational Medicine20086:34

DOI: 10.1186/1479-5876-6-34

Received: 18 February 2008

Accepted: 01 July 2008

Published: 01 July 2008

Abstract

Background

Quantification of T-cell receptor (TCR) chain families can be utilized for detection of clonal T-cell populations. Besides southern blotting and antibody-based approaches, quantitative real time PCR (qRT PCR) has been more widely applied in this context during the last years. Here, the heterogeneity of sequences within single families is the most challenging problem for exact quantification.

Method

-families were quantified using a universal reverse primer and family-specific forward primers with TaqMan technology on a light cycler instrument. Relative concentrations were calculated considering slopes and crossing points of each PCR reaction. Total expression of α/β TCR was assessed by quantification of the constant α-chain as a further control.

Results

The method was tested by serial dilutions of clonal T-cells in mononuclear cells from healthy volunteers. Calculated percentages were in good correspondence with qRT PCR results demonstrating high reliability. Duplicates showed excellent technical reproducibility. We analyzed blood samples of 20 healthy volunteers for determination of mean and standard deviation for each family. The method was applied both to tissue and blood samples from patients with carcinomas and hematological disorders.

Conclusion

We introduce a versatile method for the relative quantification of -families by real time PCR. The experimental strategy described allows the identification of alterations in the -family repertoire.

Background

T-lymphocytes are specialized mediators of the adaptive immune system, selectively destroying cells altered by viral infection or malignant transformation [1, 2]. T-cell mediated immune responses are characterized by activation and subsequent clonal expansion of antigen-specific cells. Recognition of Major Histocompatibility Complex class I (MHC-I) bound peptide is mediated by the dimeric transmembrane T-cell receptor (TCR) composed of an α- and a β-chain in the majority of cases. The high diversity of these chains is generated by stepwise recombinations of a multitude of variable (V), in case of the β-chain diversity (D), and joining (J) gene sequences with a corresponding constant (C) chain during thymic T-cell evolution [3]. V-genes are grouped in families consisting of genes with at least 50% sequence homology [4].

T lymphocyte repertoire alterations can be evaluated by TCR-diversity restriction analyses of the sequence or the length of the high variable part of the α- or β-chains (e. g. spectrotype, SSCP ('single strand conformation polymorphism'), DGGE ('denaturing gradient gel electrophoresis'), heteroduplex analysis [511]) or by TCR V-family quantification [1216]. Because of the lower described number of -families compared to -families, the higher variability of the β-chain, and the fact that each T-cell clone can express two different α-chains but only one β-chain, the -chain has been largely preferred for this type of analysis [12, 13, 17, 18].

Quantification of -families have been investigated by means of different approaches as southern blotting or, more recently, Fluorescence Activated Cell Sorter (FACS) and quantitative real time reverse transcribed PCR (qRT PCR) [5, 1214]. In contrast to other approaches, PCR-based methods could detect a higher number of different families, had higher selectivity, and were applicable to different specimens. A cumbersome limitation for qRT PCR assessments was the suboptimal establishment of standard dilution curves for exact quantification due to the high heterogeneity of sequences within each family.

Here we introduce a versatile and rapid method for qRT PCR relative quantification of -family expressions based on slope and crossing point of the respective PCR reaction overwhelming therefore the problem of establishing standard dilution curves.

Methods

Specimen collection

Peripheral blood samples were drawn form patients and healthy volunteers. Tissue samples were collected from patients with colorectal cancer who underwent therapeutical resection. Both patients and controls had given informed consent for the use of their specimens before sampling. Human T acute lymphoblastic leukemia (ALL) cell lines JURKAT, MOLT-16, and CCRF-CEM were purchased from German Collection of Microorganisms and Cell Cultures (DSMZ) and cultivated under recommended conditions.

RNA extraction and cDNA synthesis

Total RNA was extracted from peripheral blood mononuclear cells (PBMCs) or fresh tissue using TRIzol® (Invitrogen, Carlsbad, California, USA) or RNeasy® Mini Kit (Qiagen, Hilden, Nordrhein-Westfalen, Germany) according to manufacturers' instructions. RNA was quantified using a NanoDrop® ND-1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, Delaware, USA), and integrity was checked electrophoretically. Reverse transcription was performed with Omniscript Reverse Transcriptase® (Qiagen) as described previously [19]. Samples were stored at -20°C.

Relative quantification of Vβ-families

For estimation of the relative expression of a single TCR -chain, qRT PCRs were performed with a universal reverse primer HBC-rev, a TaqMan probe HBCTP-FAM, both annealing at the constant part of the β-chain (), and -family-specific forward primers (modified from [10], Table 1, Figure 1A). Nomenclature of -primers corresponded to the classification of Arden et al [4]. A Mastermix of 19 μl for each of the 29 reactions (LightCycler TaqMan Master®, Roche, Basel, Switzerland) containing 0.5 μM reverse primer HBC-rev, 0.1 μM TaqMan-probe HBCTP-FAM, and 2 μl template cDNA was prepared. For -family specific amplification, the corresponding forward primer was added to a final concentration of 0.5 μM. A negative control without forward primer was added. Amplification was performed after an initial denaturation step of 95°C for 1 min in 45 cycles of 95°C for 10 sec, 60°C for 30 sec, and 72°C for 1 sec with data aquisition. The cycling was followed by a terminal elongation step at 72°C for 2 min. Crossing points were determined using the Fitpoint algorithm as implemented in LightCycler software 3.0. Slope of each family specific reaction was determined by linear regression analyzing a dilution series (1, 0.1, and 0.01) of a cDNA mixture of diagnostic samples. The average of these slopes s ¯ MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacPC6xNi=xH8viVGI8Gi=hEeeu0xXdbba9frFj0xb9qqpG0dXdb9aspeI8k8fiI+fsY=rqGqVepae9pg0db9vqaiVgFr0xfr=xfr=xc9adbaqaaeGaciGaaiaabeqaaeqabiWaaaGcbaGafm4CamNbaebaaaa@2D5C@ was used for determination of c' as described below.
Table 1

Primers/probe for quantification of -families (modified from [10], TaqMan).

Primer

Sequence (5' – 3')

HBV1.1

CAC TCT GAA CTA AAC CTG A

HBV2

TCA ACC ATG CAA GCC TGA CC

HBV3

CGC TTC TCC CTG ATT CTG GAG TCC

HBV4

TTC CCA TCA GCC GCC CAA ACC TA

HBV5A

CTG AGA TGA ATG TGA GCA CCT TG

HBV5B

CTG AGC TGA ATG TGA ACG CCT TG

HBV6A

AGA TCC AGC GCA CAG AGC G

HBV6B

AGA TCC AGC GCA CAS AGC A

HBV7

GCC AAG TCG CTT CTC ACC TG

HBV8

TGA AGA TCC AGC CCT CAG AAC CC

HBV9

TCT CAC CTA AAT CTC CAG ACA AAG

HBV10

CCA CGG AGT CAG GGG ACA CA

HBV11

TGC CAG GCC CTC ACA TAC CTC TCA

HBV12A

GAG AAT TTC CTC CTC ACT CTG G

HBV12B

GAC CTC CCC CTC ACT CTG G

HBV13A

CTC AGG CTG CTG TCG GCT G

HBV13B

CTC AGG CTG GAG TTG GCT G

HBV14

AGG GTA CAA AGT CTC TCG AAA AG

HBV15

CAG GCA CAG GCT AAA TTC TCC

HBV16

GAA CTG GAG GAT TCT GGA GT

HBV17

GAA GGG TAC AGC GTC TCT CGG

HBV18

TTT CTG CTG AAT TTC CCA AAG AGG

HBV19

TCT CAA TGC CCC AAG AAC GCA C

HBV20

AGG TGC CCC AGA ATC TCT CAG

HBV21

TCA AAG GAG TAG ACT CCA CTC TC

HBV22

AGA TCC GGT CCA CAA AGC TG

HBV23

ATT CTG AAC TGA ACA TGA GCT CCT

HBV24

ATC CAG GAG GCC GAA CAC TTC

HBCTP-FAM

FAM-ATG GCT CAA ACA CAG CGA CCT CGG-TAMRA

HBC-rev

GGT GTG GGA GAT CTC TGC TTC

FAM: 6-carboxyfluorescin; TAMRA: 6-carboxytetramethylrhodamine, S: C or G

Figure 1

Primers and probe annealing sites and Vβ-families distribution in peripheral blood of healthy volunteers. (A) Structure of the β-chain and annealing sites of primers and of the TaqMan probe. Forward primers (HBV) anneal at the variable region, reverse primer (HBC) and TaqMan probe anneal at the constant region (B) Average percentages and standard deviations for -families in PBMCs obtained from 20 healthy controls. Family percentages Pj [%] reflecting single family expression by the sum of all measured -families are shown.

For the calculation of the percentage P of each -family j, it was assumed that the effective concentration c of each marker was
c = 10 ( a + C p s ¯ ) = 10 a 10 C p s ¯ MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacPC6xNi=xI8qiVKYPFjYdHaVhbbf9v8qqaqFr0xc9vqFj0dXdbba91qpepeI8k8fiI+fsY=rqGqVepae9pg0db9vqaiVgFr0xfr=xfr=xc9adbaqaaeGaciGaaiaabeqaaeqabiWaaaGcbaGaem4yamMaeyypa0JaeGymaeJaeGimaaZaaWbaaSqabeaadaqadaqaaiabdggaHjabgUcaRKqbaoaalaaabaGaem4qam0aaSbaaeaacqWGWbaCaeqaaaqaaiqbdohaZzaaraaaaaWccaGLOaGaayzkaaaaaOGaeyypa0JaeGymaeJaeGimaaZaaWbaaSqabeaacqWGHbqyaaGccqGHflY1cqaIXaqmcqaIWaamdaahaaWcbeqcfayaamaalaaabaGaem4qam0aaSbaaeaacqWGWbaCaeqaaaqaaiqbdohaZzaaraaaaaaaaaa@4685@
where C p was the Crossing point, s ¯ MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacPC6xNi=xH8viVGI8Gi=hEeeu0xXdbba9frFj0xb9qqpG0dXdb9aspeI8k8fiI+fsY=rqGqVepae9pg0db9vqaiVgFr0xfr=xfr=xc9adbaqaaeGaciGaaiaabeqaaeqabiWaaaGcbaGafm4CamNbaebaaaa@2D5C@ C p /log(c)] was the mean slope, and a was considered as an unknown constant for normalization. Defining a linear concentration equivalent c ' = 10 ( C p s ¯ ) MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacPC6xNi=xH8viVGI8Gi=hEeeu0xXdbba9frFj0xb9qqpG0dXdb9aspeI8k8fiI+fsY=rqGqVepae9pg0db9vqaiVgFr0xfr=xfr=xc9adbaqaaeGaciGaaiaabeqaaeqabiWaaaGcbaGaem4yamMaei4jaCIaeyypa0JaeGymaeJaeGimaaZaaWbaaSqabeaadaqadaqcfayaamaalaaabaGaem4qam0aaSbaaeaacqWGWbaCaeqaaaqaaiqbdohaZzaaraaaaaWccaGLOaGaayzkaaaaaaaa@375D@ , the percentage P [%] of a -family j equaled
P j = 10 a c ' j 100 i = 1 n ( 10 a c ' i ) = c ' j 100 i = 1 n c ' i MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacPC6xNi=xI8qiVKYPFjYdHaVhbbf9v8qqaqFr0xc9vqFj0dXdbba91qpepeI8k8fiI+fsY=rqGqVepae9pg0db9vqaiVgFr0xfr=xfr=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@6558@

assuming a constant s for all families.

Quantification of TCR constant α-chain

For determination of total TCR expression, the TCR constant α-chain (HAC) was quantified on a LightCycler® (Roche) as well as the low-abundance housekeeping gene porphobilinogen deaminidase (PBGD) for normalization as described [19]. PCR reactions were optimized using a mixture of cDNA as template. For quantification, LightCycler® FastStart DNA Master HybProbe (Roche) was used. Primer sequences, final MgCl2 concentration, and annealing temperatures T A were listed in Table 2. After optimization of PCR conditions, fragments were amplified conventionally, cloned into a pCR2.1-TOPO vector, and transformed into TOPO10' competent E. coli using TOPO TA Cloning® Kit (Invitrogen). After subcloning in liquid ImMedia® (Invitrogen) and plasmid preparation with QiaMiniprep® Kit (Qiagen), clones were linearized by digesting with EcoR I (Fermentas, St. Leon-Rot, Baden-Württemberg, Germany). Clones were sequenced, quantified spectrophotometrically and serially diluted as concentration standards. Sample concentrations were extrapolated plotting sample-crossing point C p against the regression line through standard-C p . RNA quantity was expressed as ratio plasmid equivalent HAC to PBGD.
Table 2

Primers/probes sets for quantification of PBGD and -chain (FRET).

Primer/probe

Sequence (5'-3')

TA

MgCl2

(mM)

Standard

dilutions (pg/μl)

PBGD-fwd

TGC AGG CTA CCA TCC ATG TCC CTG C

65°C

4

1/0.1/0.001

PBGD rev

AGC TGC CGT GCA ACA TCC AGG ATG T

   

PBGD-3Fl

CGT GGA ATG TTA CGA GCA GCA GTG ATG CCT ACC-Fl

   

PBGD-5LC

LC-TGT GGG TCA TCC TCA GGG CCA TCT TC-ph

   

HAC2-fwd

ACA CCT TCT TCC CCA G

60°C

3

10/1/0.01

HAC2-rev

TCC AGT TGG TGG CAT T

   

HAC2-3Fl

GTG ATT GGG TTC CGA ATC CTC C-Fl

   

HAC2-5LC

LC-CTG AAA GTG GCC GGG TTT AAT CT-ph

   

TA: Annealing temparature; Fl: Fluorescine; LC: LC Red 640; ph: phosphate

Results and Discussion

Slopes of the PCR reactions for all -families were determined by dilution series of a positive control as described (data not shown). The average slope was 3.966 with a standard deviation of 0.61. This value was used for the calculation of family percentages. For assessment of mean value and standard deviation of each family in peripheral blood, PBMCs of 20 healthy volunteers were analyzed (Figure 1B).

For assessment of reliability and reproducibility, samples containing 105 PBMCs of three healthy controls were prepared and different amounts of JURKAT-cells were added. JURKAT is a TCR α/β-expressing T-ALL cell line. Using serial dilution, aliquots of 50, 500, 5000, and 50,000 JURKAT cells were produced and subsequently added to PBMCs. Sample preparation, RNA extraction, cDNA synthesis, and qRT PCR were performed in duplicates for all concentrations for each volunteer. Results were expressed as averages of the calculated percentages of the sample duplicates. The mean difference in the percentage of each -family in all dilution duplicates was 1.01% indicating excellent technical reproducibility. For all three healthy control PBMCs spiked with JURKAT cells, a clear increase in percentage value of -family 8 was observed comparing 5000 to 500 cells per 105 PBMC (Figure 2A). Assuming 70% of mononuclear cells in peripheral blood expressing β-chains and 5.88% of the tested PBMCs belonging to Vβ8 (average percentage from 20 healthy controls), we calculated the theoretical percentages of family 8 dependent of the amounts of JURKAT cells added, which were in good correspondence with the mean of the measured values from the three healthy controls as shown in Figure 2B. As further validation, cell line MOLT-16 and CCRF-CEM were spiked in PBMCs of volunteer 2 as described above (Figure 3). Percentages of families not expressed by the cell lines relatively decreased at higher amounts of spiked cells. MOLT-16 weakly expressed a second -family, which became apparent at 5000 MOLT-16 cells per 105 PBMCs.
Figure 2

Serial dilutions of JURKAT cells expressing Vβ-family 8 spiked in PBMCs of three healthy volunteers. (A) measured percentages of family 8 in case of 50, 500, 5000, 50 000 JURKAT cells added to 100 000 PBMCs; (B) mean percentages of the three volunteers compared with theoretical values calculated assuming 5.88% family 8 without JURKAT cells and 70% TCR α/β positive cells in 100 000 PBMCs. P j : -chain relative expression.

Figure 3

Serial dilutions of CCRF-CEM (Vβ9) and MOLT-16 (Vβ2, Vβ18) cell lines in PBMCs of a healthy volunteer. Measured percentages of all families in case of 50, 500, 5000, 50 000 CCRF-CEM cells (A) or MOLT-16 cells (B) added to 100 000 PBMCs of volunteer 2. Dilutions, RNA extraction, cDNA synthesis and qRT PCR are performed in duplicated. Mean percentages of each dilution step were shown. P j : -chain relative expression.

Because total amount of TCR α/β expression could be different among various types of specimens, we quantified the constant α-chain as a control of sample quality. HAC expression was 50-fold higher in PBMCs than in tissue samples (data not shown).

In this study, we introduced a new approach for estimating the distribution of -family expression in a population of T-cells. To determine the effective concentration of a transcript, standard dilutions of the specific fragment are generally utilized. In case of -family analysis, not a single target but a big amount of different close related transcripts has to be quantified because of the high variability of the Complement Determining Region 3 (CDR3) both in length and sequence. Therefore, establishment of a PCR in which a dilution series of a single amplicon (standard curve) is used for normalization, besides increase in costs, can not lead to exact results even using probes annealing to the constant part of the -chain. As PCR reactions lead to an exponential increase of produced fragments, and as a result crossing point values have to be interpreted logarithmically concerning the effective concentration of the target, it is possible to calculate percentages without normalization and independently from the sample concentration when crossing points and slope are taken into consideration. For these reasons, in order to by-pass CDR3 diversity, we established a system in which relative quantification is based on the comparison of crossing points, rather than performing a family-by-family quantification using single sequence plasmids for normalization.

There are two drawbacks on the approach: First, because the system is ,normalized' by the sum of its c'-values, results from runs with more than three lacking crossing points (because of suboptimal sample quality or technical problems) will not be informative. Second, the high standard deviation of the slopes limits the correctness of the mathematical procedure. Exemplary calculations showed that this effect was of no practical relevance as long as the concentration difference between compared samples, reflected by the difference between the sums of all c' (c' total ), did not exceed a factor of 100 (data not shown). Nevertheless, this effect may play a role comparing blood with tissue as HAC/PBGD ratio in tissue is lower than in PBMCs. If the difference would be much higher, mathematical corrections of the percentage of a single predominant family should be performed considering Δc' total and s j .

The method was applied to blood samples of patients with hematological diseases and to colon carcinoma tissues. Three examples with representative patterns were shown in Figure 4. Pattern A showed the T-cell family repertoire of a patient affected by T prolymphocytic leukemia with 98.0 leukocytes per nl and 89% CD4/CD8 positive cells (FACS analysis, data not shown) in peripheral blood. The pathological clone expressed -family 17 and represented more than 98% of all TCR α/β positive lymphocytes in peripheral blood. Pattern B showed a patient with suspected T-/NK-LGL lymphoproliferation. -families 6b, 22, and 24 exceeded mean plus two standard deviations as determined in twenty healthy controls. Therefore, a monoclonal TCR α/β expressing lymphoproliferation was unlikely and findings had to be interpreted as reactive T cell expansion. Pattern C showed the family distribution in a representative colon carcinoma tissue sample. A higher percentage of -family 14 compared to other families was observed. If TCR restriction in the tumor compartment reflects a spontaneous expansion of tumor-specific T-cell clones is still matter of debate.
Figure 4

Relative quantification of TCR-Vβ-families: Examples of clinical samples. (A) T prolymphocytic leukemia, (B) suspected T/NK-LGL lymphoproliferation, (C) Colon carcinoma tissue. Peripheral blood -chain values (A, B) exceeding mean plus two standard deviations in healthy controls are marked with asterisk. P j : -chain relative expression.

Compared to techniques characterizing the CDR3 region (e.g. spectrotyping, SSCP, DGGE), the method described is less time-consuming and useful for high-throughput screening analyses. As for spectrotyping, conclusive proof of clonality can only be achieved by sequencing. Approaches like TC landscape combine CDR3 length analysis with -family quantification by FACS quantification in order to improve sensitivity [5]. Due to higher number of detectable families and higher sensitivity, the use of a high-throughput PCR-based quantification algorithm could make a combined approach even more effective [16].

Conclusion

We present a novel and versatile approach for high-throughput family quantification. Our approach is suitable for samples from blood or bone marrow as well as from tissue. Because of high reproducibility, comparative analyses of samples in different time points or from different compartments are possible.

Declarations

Acknowledgements

We thank Susanne Wojtke for excellent technical assistance.

Authors’ Affiliations

(1)
University Hospital Benjamin Franklin, Medizinische Klinik III, Hematology, Oncology, and Transfusion Medicine, Charité Universitätsmedizin Berlin
(2)
University of Würzburg, Clinic for Dermatology, Allergology, and Venerology

References

  1. Andersen MH, Schrama D, Thor Straten P, Becker JC: Cytotoxic T Cells. J Invest Dermatol. 2006, 126 (1): 32-41. 10.1038/sj.jid.5700001.View ArticlePubMedGoogle Scholar
  2. Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P: Human T Cell Response Against Melanoma. Annu Rev Immunol. 2006, 24: 175-208. 10.1146/annurev.immunol.24.021605.090733.View ArticlePubMedGoogle Scholar
  3. Davis MM, Bjorkman PJ: T cell antigen receptor genes and T-cell recognition. Nature. 1988, 334 (6181): 395-402. 10.1038/334395a0.View ArticlePubMedGoogle Scholar
  4. Arden B, Clark SP, Kabelitz D, Mak TW: Human T-cell receptor variable gene segment families. Immunogenetics. 1995, 42 (6): 455-500.PubMedGoogle Scholar
  5. Pilch H, Höhn H, Freitag K, Neukirch C, Necker A, Haddad P, Tanner B, Knapstein PG, Maeurer MJ: Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis. Clin Diagn Lab Immunol. 2002, 9 (2): 257-266. 10.1128/CDLI.9.2.257-266.2002.PubMed CentralPubMedGoogle Scholar
  6. Yao XS, Diao Y, Sun WB, Luo JM, Qin M, Tang XY: Analysis of the CDR3 length repertoire and the diversity of TCR alpha chain in human peripheral blood T lymphocytes. Cell Mol Immunol. 2007, 4 (3): 215-220.PubMedGoogle Scholar
  7. Long SA, Khalili J, Ashe J, Berenson R, Ferrand C, Bonyhadi M: Standardized analysis for the quantification of Vbeta CDR3 T-cell receptor diversity. J Immunol Methods. 2006, 317 (1-2): 100-113. 10.1016/j.jim.2006.09.015.View ArticlePubMedGoogle Scholar
  8. Collette A, Cazenave PA, Pied S, Six A: New methods and software tools for high throughput CDR3 spectratyping. Application to T lymphocyte repertoire modifications during experimental malaria. J Immunol Methods. 2003, 278 (1-2): 105-116. 10.1016/S0022-1759(03)00225-4.View ArticlePubMedGoogle Scholar
  9. Chino Y, Murata H, Goto D, Matsumoto I, Tsutsumi A, Sakamoto T, Ohtsuka M, Sekisawa K, Ito S, Sumida T: T cell receptor BV gene repertoire of lymphocytes in bronchoalveolar lavage fluid of polymyositis/dermatomyositis patients with interstitial pneumonitis. Int J Mol Med. 2006, 17: 101-109.PubMedGoogle Scholar
  10. thor Straten P, Barfoed A, Seremet T, Saeterdal I, Zeuthen J, Guldberg P: Detection and characterization of alpha-beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE). Biotechniques. 1998, 25 (2): 244-250.PubMedGoogle Scholar
  11. van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003, 17 (12): 2257-2317. 10.1038/sj.leu.2403202.View ArticlePubMedGoogle Scholar
  12. Willhauk M, Möhler T, Scheibenbogen C, Pawlita M, Brossart P, Schmier JW, Keilholz U: T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy . Clin Cancer Res. 1996, 2 (4): 767-772.Google Scholar
  13. Brewer JL, Ericson SG: An improved methodology to detect human T cell receptor beta variable family gene expression patterns. J Immunol Methods. 2005, 302 (1-2): 54-67. 10.1016/j.jim.2005.04.014.View ArticlePubMedGoogle Scholar
  14. Lim A, Baron V, Ferradini L, Bonneville M, Kourilsky P, Pannetier C: Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses. J Immunol Methods. 2002, 261 (1-2): 177-194. 10.1016/S0022-1759(02)00004-2.View ArticlePubMedGoogle Scholar
  15. Sun W, Popat U, Hutton G, Zang YC, Krance R, Carrum G, Land GA, Heslop H, Brenner M, Zhang JZ: Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stemm-cell grafts in multiple sclerosis. Brain. 2004, 127 (Pt 5): 996-1000. 10.1093/brain/awh117.View ArticlePubMedGoogle Scholar
  16. Degauque N, Schadendorf D, Brouard S, Guillet M, Sébille F, Höhn H, Pallier A, Ruiz C, Dupont A, Chapin S, Hofmann U, Maeurer M, Soulillou JP: Blood T-cell Vbeta transcriptome in melanoma patients. Int J Cancer. 2004, 110 (5): 721-729. 10.1002/ijc.20149.View ArticlePubMedGoogle Scholar
  17. Gagne K, Brouard S, Giral M, Sebille F, Moreau A, Guillet M, Bignon JD, Imbert BM, Cuturi MC, Soulillou JP: Highly altered V beta repertoire of T cells Infiltrating long-term rejected kidney allografts. J Immunol. 2000, 164 (3): 1553-1563.View ArticlePubMedGoogle Scholar
  18. Thor Straten P, Schrama D, Andersen MH, Becker JC: T-cell clonotypes in cancer. J Transl Med. 2004, 2 (1): 11-10.1186/1479-5876-2-11.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Keilholz U, Goldin-Lang P, Bechrakis NE, Max N, Letsch A, Schmittel A, Scheibenbogen C, Heufelder K, Eggermont A, Thiel E: Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction. Clin Cancer Res. 2004, 10 (5): 1605-1612. 10.1158/1078-0432.CCR-0610-3.View ArticlePubMedGoogle Scholar

Copyright

© Ochsenreither et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement